The high expression of PDZ and LIM domain 2 (PDLIM2), a member of ALP, was also correlated with infiltrating immune cells and predicted poor prognoses in patients with prostate cancer [20]. This evidence concerns the gene PDLIM2 and prostate carcinoma.